Paladin Labs
Neelam Bance is a highly experienced professional in the healthcare industry, currently serving as Co-Founder and CEO of MedGeneius Inc since January 2024, providing innovative pharmacogenetic solutions. Bance also holds roles in market research at Pulse Insights, business development at TimedRight, and Director of Infusion Services at Auxilium Health. Prior to these positions, significant contributions were made as Healthcare Solutions Manager at Paladin Labs and as Director of Marketing and Business Development at Inagene Diagnostics. Earlier roles include Director and Marketing Manager at Sunovion Pharmaceuticals, and various marketing and sales positions at Eli Lilly and Company, where successful medication launches were achieved and notable collaborations with healthcare professionals were established. Neelam Bance holds an MBA from the Schulich School of Business at York University and a Bachelor's Degree in Biology from the University of Toronto.
This person is not in any offices
Paladin Labs
Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. Paladin has a focused marketing and sales organization that has helped it evolve into a well-known Canadian specialty pharmaceutical company with a breadth of products. Paladin is an operating company of Endo International plc (NASDAQ: ENDP), a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization.